LyGenesis, a clinical-stage biotechnology company developing cell therapies for large unmet medical needs, announced today …
![Allogenic Regenerative Cell Therapy for End-Stage Liver Disease](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/LyGenesis_cell_solution_with_hepatocytes_in_suspension.jpg?resize=600%2C427&ssl=1)
![Allogenic Regenerative Cell Therapy for End-Stage Liver Disease](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/LyGenesis_cell_solution_with_hepatocytes_in_suspension.jpg?resize=600%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
LyGenesis, a clinical-stage biotechnology company developing cell therapies for large unmet medical needs, announced today …
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the …